Managing chronic obstructive pulmonary disease (COPD) in real life: the role of adding tiotropium bromide in relation to quality of life and costs Source: Eur Respir J 2005; 26: Suppl. 49, 292s Year: 2005
Improvement in HRQoL of COPD patients after 9 months‘ treatment with tiotropium bromide: use of a new scale for daily medical practice Source: Eur Respir J 2005; 26: Suppl. 49, 290s Year: 2005
Knowledge and skills for inhaled drugs before and after a rehabilitation program in COPD: a real life study Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018
Aclidinium bromide improves symptoms and sleep quality in COPD: a pilot study Source: Eur Respir J, 49 (6) 1700485; 10.1183/13993003.00485-2017 Year: 2017
Importance of inhaler device use status in the control of asthma and COPD: a real life study. Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018
QVA149 provides significant symptomatic benefit to COPD patients as measured by a new symptom e-diary: The SHINE study Source: International Congress 2015 – New data on established treatments for COPD Year: 2015
Dual bronchodilation with once-daily QVA149 improves dyspnea and health status and reduces symptoms and rescue medication use in patients with COPD: The IGNITE trials Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013
Can the use of adaptive aerosol delivery technology increase the quality of life for patients with COPD? Source: Eur Respir J 2007; 30: Suppl. 51, 611s Year: 2007
Tiotropium + olodaterol fixed-dose combination shows clinically meaningful improvements in quality of life versus placebo Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015
Real life experience with omalizumab and mepolizumab in severe asthma : do patient baseline features preclude effectiveness comparison ? Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019
The influence of fenspiride in complex therapy on quality of life in COPD patients Source: Annual Congress 2010 - COPD: management Year: 2010
ACCORD COPD I: Twice-daily aclidinium bromide improves quality of life and dyspnea in COPD patients Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011
The effect of community lung rehabilitation guidance on the quality of life of patients with COPD. Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care Year: 2018
HELPing people with very severe COPD: Feasibility study of a novel holistic intervention Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013
Budesonide/formoterol improves the wellbeing of patients with COPD: results from a real-life setting Source: Eur Respir J 2005; 26: Suppl. 49, 289s Year: 2005
How COPD patients understand their disease and what are their future expectations? Source: International Congress 2016 – Smoking-related diseases Year: 2016
How does patient‘s quality of life guide their preferences regarding asthma therapy? Source: Annual Congress 2006 - Respiratory disease managment in primary care Year: 2006
Effect of salmeterol/fluticasone propionate versus tiotropium bromide on withdrawal rate, health status, lung function and mortality: INSPIRE (investigating new standards for prophylaxis in reduction of exacerbations) study Source: Eur Respir J 2007; 30: Suppl. 51, 34s Year: 2007
TriOptimize VII: Improvement of health-related quality of life after 3 months treatmentwith extrafine single inhaler triple therapy in COPD patients in a real-world setting. Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020